These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 23053135

  • 1. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
    Bieniek KF, Murray ME, Rutherford NJ, Castanedes-Casey M, DeJesus-Hernandez M, Liesinger AM, Baker MC, Boylan KB, Rademakers R, Dickson DW.
    Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
    [Abstract] [Full Text] [Related]

  • 2. Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant.
    King A, Al-Sarraj S, Troakes C, Smith BN, Maekawa S, Iovino M, Spillantini MG, Shaw CE.
    Acta Neuropathol; 2013 Feb; 125(2):303-10. PubMed ID: 23053136
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene.
    Davidson YS, Flood L, Robinson AC, Nihei Y, Mori K, Rollinson S, Richardson A, Benson BC, Jones M, Snowden JS, Pickering-Brown S, Haass C, Lashley T, Mann DMA.
    Acta Neuropathol Commun; 2017 Apr 21; 5(1):31. PubMed ID: 28431575
    [Abstract] [Full Text] [Related]

  • 4. Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations.
    Sakae N, Roemer SF, Bieniek KF, Murray ME, Baker MC, Kasanuki K, Graff-Radford NR, Petrucelli L, Van Blitterswijk M, Rademakers R, Dickson DW.
    Ann Clin Transl Neurol; 2019 Sep 21; 6(9):1782-1796. PubMed ID: 31448566
    [Abstract] [Full Text] [Related]

  • 5. Amygdala TDP-43 Pathology in Frontotemporal Lobar Degeneration and Motor Neuron Disease.
    Takeda T, Seilhean D, Le Ber I, Millecamps S, Sazdovitch V, Kitagawa K, Uchihara T, Duyckaerts C.
    J Neuropathol Exp Neurol; 2017 Sep 01; 76(9):800-812. PubMed ID: 28859337
    [Abstract] [Full Text] [Related]

  • 6. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
    Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, Rogelj B, Al-Chalabi A, Hortobágyi T, Shaw CE.
    Acta Neuropathol; 2011 Dec 01; 122(6):691-702. PubMed ID: 22101323
    [Abstract] [Full Text] [Related]

  • 7. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
    Brettschneider J, Van Deerlin VM, Robinson JL, Kwong L, Lee EB, Ali YO, Safren N, Monteiro MJ, Toledo JB, Elman L, McCluskey L, Irwin DJ, Grossman M, Molina-Porcel L, Lee VM, Trojanowski JQ.
    Acta Neuropathol; 2012 Jun 01; 123(6):825-39. PubMed ID: 22426854
    [Abstract] [Full Text] [Related]

  • 8. No interaction between tau and TDP-43 pathologies in either frontotemporal lobar degeneration or motor neurone disease.
    Robinson AC, Thompson JC, Weedon L, Rollinson S, Pickering-Brown S, Snowden JS, Davidson YS, Mann DM.
    Neuropathol Appl Neurobiol; 2014 Dec 01; 40(7):844-54. PubMed ID: 24861427
    [Abstract] [Full Text] [Related]

  • 9. Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation.
    Bigio EH, Weintraub S, Rademakers R, Baker M, Ahmadian SS, Rademaker A, Weitner BB, Mao Q, Lee KH, Mishra M, Ganti RA, Mesulam MM.
    Neuropathology; 2013 Apr 01; 33(2):122-33. PubMed ID: 22702520
    [Abstract] [Full Text] [Related]

  • 10. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.
    Gallagher MD, Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer JD, Halliday G, Van Broeckhoven C, Seilhean D, Shaw PJ, Frosch MP, Alafuzoff I, Antonell A, Bogdanovic N, Brooks W, Cairns NJ, Cooper-Knock J, Cotman C, Cras P, Cruts M, De Deyn PP, DeCarli C, Dobson-Stone C, Engelborghs S, Fox N, Galasko D, Gearing M, Gijselinck I, Grafman J, Hartikainen P, Hatanpaa KJ, Highley JR, Hodges J, Hulette C, Ince PG, Jin LW, Kirby J, Kofler J, Kril J, Kwok JB, Levey A, Lieberman A, Llado A, Martin JJ, Masliah E, McDermott CJ, McKee A, McLean C, Mead S, Miller CA, Miller J, Munoz DG, Murrell J, Paulson H, Piguet O, Rossor M, Sanchez-Valle R, Sano M, Schneider J, Silbert LC, Spina S, van der Zee J, Van Langenhove T, Warren J, Wharton SB, White CL, Woltjer RL, Trojanowski JQ, Lee VM, Van Deerlin V, Chen-Plotkin AS.
    Acta Neuropathol; 2014 Mar 01; 127(3):407-18. PubMed ID: 24442578
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneous ribonuclear protein E2 (hnRNP E2) is associated with TDP-43-immunoreactive neurites in Semantic Dementia but not with other TDP-43 pathological subtypes of Frontotemporal Lobar Degeneration.
    Davidson YS, Robinson AC, Flood L, Rollinson S, Benson BC, Asi YT, Richardson A, Jones M, Snowden JS, Pickering-Brown S, Lashley T, Mann DMA.
    Acta Neuropathol Commun; 2017 Jun 30; 5(1):54. PubMed ID: 28666471
    [Abstract] [Full Text] [Related]

  • 12. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
    Armstrong RA, Carter D, Cairns NJ.
    Neuropathol Appl Neurobiol; 2012 Feb 30; 38(1):25-38. PubMed ID: 21696412
    [Abstract] [Full Text] [Related]

  • 13. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
    Papegaey A, Eddarkaoui S, Deramecourt V, Fernandez-Gomez FJ, Pantano P, Obriot H, Machala C, Anquetil V, Camuzat A, Brice A, Maurage CA, Le Ber I, Duyckaerts C, Buée L, Sergeant N, Buée-Scherrer V.
    Acta Neuropathol Commun; 2016 Jul 19; 4(1):74. PubMed ID: 27435172
    [Abstract] [Full Text] [Related]

  • 14. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
    Van Langenhove T, van der Zee J, Gijselinck I, Engelborghs S, Vandenberghe R, Vandenbulcke M, De Bleecker J, Sieben A, Versijpt J, Ivanoiu A, Deryck O, Willems C, Dillen L, Philtjens S, Maes G, Bäumer V, Van Den Broeck M, Mattheijssens M, Peeters K, Martin JJ, Michotte A, Santens P, De Jonghe P, Cras P, De Deyn PP, Cruts M, Van Broeckhoven C.
    JAMA Neurol; 2013 Mar 01; 70(3):365-73. PubMed ID: 23338682
    [Abstract] [Full Text] [Related]

  • 15. Drosha inclusions are new components of dipeptide-repeat protein aggregates in FTLD-TDP and ALS C9orf72 expansion cases.
    Porta S, Kwong LK, Trojanowski JQ, Lee VM.
    J Neuropathol Exp Neurol; 2015 Apr 01; 74(4):380-7. PubMed ID: 25756586
    [Abstract] [Full Text] [Related]

  • 16. Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration.
    Yousef A, Robinson JL, Irwin DJ, Byrne MD, Kwong LK, Lee EB, Xu Y, Xie SX, Rennert L, Suh E, Van Deerlin VM, Grossman M, Lee VM, Trojanowski JQ.
    Acta Neuropathol Commun; 2017 Sep 06; 5(1):68. PubMed ID: 28877758
    [Abstract] [Full Text] [Related]

  • 17. A pathogenic progranulin mutation and C9orf72 repeat expansion in a family with frontotemporal dementia.
    Lashley T, Rohrer JD, Mahoney C, Gordon E, Beck J, Mead S, Warren J, Rossor M, Revesz T.
    Neuropathol Appl Neurobiol; 2014 Jun 06; 40(4):502-13. PubMed ID: 24286341
    [Abstract] [Full Text] [Related]

  • 18. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME, DeJesus-Hernandez M, Rutherford NJ, Baker M, Duara R, Graff-Radford NR, Wszolek ZK, Ferman TJ, Josephs KA, Boylan KB, Rademakers R, Dickson DW.
    Acta Neuropathol; 2011 Dec 06; 122(6):673-90. PubMed ID: 22083254
    [Abstract] [Full Text] [Related]

  • 19. Increased prevalence of granulovacuolar degeneration in C9orf72 mutation.
    Riku Y, Duyckaerts C, Boluda S, Plu I, Le Ber I, Millecamps S, Salachas F, Brainbank NeuroCEB Neuropathology Network, Yoshida M, Ando T, Katsuno M, Sobue G, Seilhean D.
    Acta Neuropathol; 2019 Nov 06; 138(5):783-793. PubMed ID: 31144027
    [Abstract] [Full Text] [Related]

  • 20. A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation.
    Armstrong RA, Cairns NJ.
    Histol Histopathol; 2011 Feb 06; 26(2):185-90. PubMed ID: 21154232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.